Gomiliximab

From Self-sufficiency
Jump to: navigation, search
Gomiliximab
Monoclonal antibody
Type Whole antibody
Source Template:Infobox drug/mab source
Target CD23
Identifiers
CAS Number 357613-86-6
ATC code none
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Gomiliximab is a monoclonal antibody acting as an immunosuppressive drug for the treatment of allergic asthma. It targets the low affinity IgE receptor (FcεRII or CD23).[1] The drug is a chimeric antibody from Macaca irus and Homo sapiens.[1]

This drug was developed by IDEC Pharmaceuticals Corporation.

References

  1. 1.0 1.1 Statement On A Nonproprietary Name Adopted By The Usan Council - Gomiliximab, American Medical Association.